Advertisement
Gamma's CEO Peter Cunningham commented, "The combination of Gamma's innovative product range and promotion programs with distribution by International Wholesale Supply, Inc and retail support by and retail presence, Terrible Herbst should significantly expand Gamma's revenues. All three companies are strong, innovative and quick to seize opportunities." Mr. Cunningham went on to say, "For Jugular(R) brand, our key measure is market share, and Terrible Herbst is the C-store trend setter nationwide. C-stores get the highest daily foot traffic which is important now as the retail landscape changes. C-stores are becoming more like supermarkets, pharmacies are becoming more like C-stores and supermarkets now offer all categories of grocery, sundry and pharmacy products. With the Terrible Herbst experience, Gamma is positioned to take advantage of the change in the retail channels nationwide."
Advertisement
Gamma Pharmaceuticals Inc. (www.gammapharma.com) is a marketing and product formulation company. We have created, registered and branded innovative product lines including Nutritional Supplements, Personal Care Products and Over-The-Counter (OTC) pharmaceuticals. At present, Gamma manufactures in North America, and distributes in the United States and China. Gamma's products utilize our proprietary "Gel Delivery Technology" (Gel Delivery Technology Gamma(R)). Gamma offers consumers one of the industry's only full suite of gel product forms, including solid gels, liquid gels, crystal gels and gel strips. Gamma's leading position in gel technologies enables the Company to profit from consumer preferences which are moving away from pills and capsules and towards new and more effective gel product forms. Gamma presents consumers with a choice that offers a more pleasant experience with convenient, great tasting and fast acting product forms. Gamma has formulated products for market categories that are growing at as much as 60% per year. Gamma targets consumers in the fast growing Greater China and U.S. wellness and healthcare markets (LOHAS) and the youth energy products market with Gel products. Gamma uses third party distributors or sells direct to retail.
Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.
Contact: Gamma Pharmaceuticals Inc. Joe Cunningham 702 989 5262 651 204 2048 www.gammapharma.com [email protected]
SOURCE Gamma Pharmaceuticals Inc.
